Published in Hum Genet on May 20, 2011
Additional annotation enhances potential for biologically-relevant analysis of the Illumina Infinium HumanMethylation450 BeadChip array. Epigenetics Chromatin (2013) 2.93
Gene silencing in X-chromosome inactivation: advances in understanding facultative heterochromatin formation. Nat Rev Genet (2011) 2.39
Translating dosage compensation to trisomy 21. Nature (2013) 1.75
X chromosome regulation: diverse patterns in development, tissues and disease. Nat Rev Genet (2014) 1.36
MethLAB: a graphical user interface package for the analysis of array-based DNA methylation data. Epigenetics (2012) 1.24
Landscape of DNA methylation on the X chromosome reflects CpG density, functional chromatin state and X-chromosome inactivation. Hum Mol Genet (2014) 1.15
Escape from X inactivation varies in mouse tissues. PLoS Genet (2015) 1.10
Cancer epigenetics: a brief review. ILAR J (2012) 1.09
Accounting for eXentricities: analysis of the X chromosome in GWAS reveals X-linked genes implicated in autoimmune diseases. PLoS One (2014) 1.04
Early de novo DNA methylation and prolonged demethylation in the muscle lineage. Epigenetics (2013) 1.00
Illuminating potential technical artifacts of DNA-methylation array probes. Am J Hum Genet (2012) 1.00
Analysis of expressed SNPs identifies variable extents of expression from the human inactive X chromosome. Genome Biol (2013) 0.99
An integrative analysis of DNA methylation and RNA-Seq data for human heart, kidney and liver. BMC Syst Biol (2011) 0.98
Grasping nettles: cellular heterogeneity and other confounders in epigenome-wide association studies. Hum Mol Genet (2014) 0.97
Bisphenol A-associated epigenomic changes in prepubescent girls: a cross-sectional study in Gharbiah, Egypt. Environ Health (2013) 0.93
The effects of perinatal testosterone exposure on the DNA methylome of the mouse brain are late-emerging. Biol Sex Differ (2014) 0.92
Variable escape from X-chromosome inactivation: identifying factors that tip the scales towards expression. Bioessays (2014) 0.91
Sex differences in the genome-wide DNA methylation pattern and impact on gene expression, microRNA levels and insulin secretion in human pancreatic islets. Genome Biol (2014) 0.89
Cross-reactive DNA microarray probes lead to false discovery of autosomal sex-associated DNA methylation. Am J Hum Genet (2012) 0.88
XWAS: A Software Toolset for Genetic Data Analysis and Association Studies of the X Chromosome. J Hered (2015) 0.87
Spread of X-chromosome inactivation into autosomal sequences: role for DNA elements, chromatin features and chromosomal domains. Hum Mol Genet (2013) 0.87
Androgen receptor gene and sex-specific Alzheimer's disease. Neurobiol Aging (2013) 0.83
Sexually dimorphic characteristics of the small intestine and colon of prepubescent C57BL/6 mice. Biol Sex Differ (2014) 0.82
Targeting of >1.5 Mb of human DNA into the mouse X chromosome reveals presence of cis-acting regulators of epigenetic silencing. Genetics (2012) 0.81
Unusual maintenance of X chromosome inactivation predisposes female lymphocytes for increased expression from the inactive X. Proc Natl Acad Sci U S A (2016) 0.80
WBSA: web service for bisulfite sequencing data analysis. PLoS One (2014) 0.80
Epigenetics in lung fibrosis: from pathobiology to treatment perspective. Curr Opin Pulm Med (2015) 0.79
Comparison of clustering methods for investigation of genome-wide methylation array data. Front Genet (2011) 0.78
Female chromosome X mosaicism is age-related and preferentially affects the inactivated X chromosome. Nat Commun (2016) 0.78
Transcription start sites and epigenetic analysis of the HSD17B10 proximal promoter. BMC Biochem (2013) 0.77
Aberrant Cosmc genes result in Tn antigen expression in human colorectal carcinoma cell line HT-29. Int J Clin Exp Pathol (2015) 0.77
Characterization of X chromosome inactivation using integrated analysis of whole-exome and mRNA sequencing. PLoS One (2014) 0.77
Recent progress towards understanding the role of DNA methylation in human placental development. Reproduction (2016) 0.77
Regulation of TIMP-1 in Human Placenta and Fetal Membranes by lipopolysaccharide and demethylating agent 5-aza-2'-deoxycytidine. Reprod Biol Endocrinol (2015) 0.76
Characterization of CpG sites that escape methylation on the inactive human X-chromosome. Epigenetics (2015) 0.75
Association of skewed X-chromosome inactivation with FMR1 CGG repeat length and anti-Mullerian hormone levels: a cohort study. Reprod Biol Endocrinol (2017) 0.75
Kidney Dysfunction in Adult Offspring Exposed In Utero to Type 1 Diabetes Is Associated with Alterations in Genome-Wide DNA Methylation. PLoS One (2015) 0.75
Hypomethylation of interleukin-6 (IL-6) gene increases the risk of essential hypertension: a matched case-control study. J Hum Hypertens (2017) 0.75
Basic local alignment search tool. J Mol Biol (1990) 659.07
A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics (2003) 82.89
Galaxy: a comprehensive approach for supporting accessible, reproducible, and transparent computational research in the life sciences. Genome Biol (2010) 39.63
Human DNA methylomes at base resolution show widespread epigenomic differences. Nature (2009) 34.27
Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat Genet (2007) 32.41
Large-scale analysis of the human and mouse transcriptomes. Proc Natl Acad Sci U S A (2002) 25.47
CpG-rich islands and the function of DNA methylation. Nature (1986) 24.90
CpG islands in vertebrate genomes. J Mol Biol (1987) 23.16
A Bayesian deconvolution strategy for immunoprecipitation-based DNA methylome analysis. Nat Biotechnol (2008) 21.72
Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome. Nat Genet (2007) 20.22
The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores. Nat Genet (2009) 18.90
Assumption-free analysis of quantitative real-time polymerase chain reaction (PCR) data. Neurosci Lett (2003) 18.34
DNA methylation profiling of human chromosomes 6, 20 and 22. Nat Genet (2006) 18.08
Galaxy: a web-based genome analysis tool for experimentalists. Curr Protoc Mol Biol (2010) 17.00
The UCSC Genome Browser database: update 2011. Nucleic Acids Res (2010) 16.24
Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells. Nat Genet (2005) 15.37
Comprehensive analysis of CpG islands in human chromosomes 21 and 22. Proc Natl Acad Sci U S A (2002) 12.33
X-inactivation profile reveals extensive variability in X-linked gene expression in females. Nature (2005) 12.06
A genome-wide analysis of CpG dinucleotides in the human genome distinguishes two distinct classes of promoters. Proc Natl Acad Sci U S A (2006) 10.63
Amplification efficiency: linking baseline and bias in the analysis of quantitative PCR data. Nucleic Acids Res (2009) 9.64
DNA methylation and the frequency of CpG in animal DNA. Nucleic Acids Res (1980) 9.34
X inactivation, differentiation, and DNA methylation. Cytogenet Cell Genet (1975) 8.74
A novel CpG island set identifies tissue-specific methylation at developmental gene loci. PLoS Biol (2008) 7.95
Comparison of Beta-value and M-value methods for quantifying methylation levels by microarray analysis. BMC Bioinformatics (2010) 7.78
Tissue-specific expression and regulation of sexually dimorphic genes in mice. Genome Res (2006) 6.45
Gene body-specific methylation on the active X chromosome. Science (2007) 6.33
An integrated resource for genome-wide identification and analysis of human tissue-specific differentially methylated regions (tDMRs). Genome Res (2008) 4.84
The DNA methylation paradox. Trends Genet (1999) 4.40
Dosage compensation of the active X chromosome in mammals. Nat Genet (2005) 4.31
Evolution on the X chromosome: unusual patterns and processes. Nat Rev Genet (2006) 4.29
DNA methylation is the primary silencing mechanism for a set of germ line- and tumor-specific genes with a CpG-rich promoter. Mol Cell Biol (1999) 3.76
Methylation of the hypoxanthine phosphoribosyltransferase locus on the human X chromosome: implications for X-chromosome inactivation. Proc Natl Acad Sci U S A (1984) 3.53
Orphan CpG islands identify numerous conserved promoters in the mammalian genome. PLoS Genet (2010) 3.38
High definition profiling of mammalian DNA methylation by array capture and single molecule bisulfite sequencing. Genome Res (2009) 3.08
DNA methylation of the first exon is tightly linked to transcriptional silencing. PLoS One (2011) 2.80
RNA sequencing shows no dosage compensation of the active X-chromosome. Nat Genet (2010) 2.71
Chromatin and sequence features that define the fine and gross structure of genomic methylation patterns. Genome Res (2010) 2.25
Transformation with DNA from 5-azacytidine-reactivated X chromosomes. Proc Natl Acad Sci U S A (1982) 2.22
An evaluation of new criteria for CpG islands in the human genome as gene markers. Bioinformatics (2004) 2.19
X inactivation and the complexities of silencing a sex chromosome. Curr Opin Cell Biol (2009) 2.09
Global, comparative analysis of tissue-specific promoter CpG methylation. Genomics (2007) 2.01
Histone modification patterns associated with the human X chromosome. EMBO Rep (2006) 1.99
Replication timing-related and gene body-specific methylation of active human genes. Hum Mol Genet (2010) 1.92
X-linked mental retardation. J Med Genet (1974) 1.91
X-linked mental retardation: many genes for a complex disorder. Curr Opin Genet Dev (2006) 1.73
Heterogeneous gene expression from the inactive X chromosome: an X-linked gene that escapes X inactivation in some human cell lines but is inactivated in others. Proc Natl Acad Sci U S A (1999) 1.52
Sites of differential DNA methylation between placenta and peripheral blood: molecular markers for noninvasive prenatal diagnosis of aneuploidies. Am J Pathol (2009) 1.46
5-Azacytidine-induced reactivation of the human X chromosome-linked PGK1 gene is associated with a large region of cytosine demethylation in the 5' CpG island. Proc Natl Acad Sci U S A (1990) 1.45
Complete concordance between glucose-6-phosphate dehydrogenase activity and hypomethylation of 3' CpG clusters: implications for X chromosome dosage compensation. Nucleic Acids Res (1984) 1.42
Reactivation of inactive X-linked genes. Dev Genet (1994) 1.34
Comparison of X-chromosome inactivation patterns in multiple tissues from human females. J Med Genet (2007) 1.25
X inactivation analysis and DNA methylation studies of the ubiquitin activating enzyme E1 and PCTAIRE-1 genes in human and mouse. Hum Mol Genet (1996) 1.23
DNA methylation stabilizes X chromosome inactivation in eutherians but not in marsupials: evidence for multistep maintenance of mammalian X dosage compensation. Proc Natl Acad Sci U S A (1987) 1.22
Inactive X chromosome-specific reduction in placental DNA methylation. Hum Mol Genet (2009) 1.22
Inactivation status of PCDH11X: sexual dimorphisms in gene expression levels in brain. Hum Genet (2006) 1.14
Methylation analysis of a marsupial X-linked CpG island by bisulfite genomic sequencing. Genome Res (1996) 1.14
Epigenetic modifications on X chromosomes in marsupial and monotreme mammals and implications for evolution of dosage compensation. Proc Natl Acad Sci U S A (2010) 1.10
X-inactivation pattern in the liver of a manifesting female with ornithine transcarbamylase (OTC) deficiency. Clin Genet (1998) 1.03
Absence of methylation of a CpG-rich region at the 5' end of the MIC2 gene on the active X, the inactive X, and the Y chromosome. Proc Natl Acad Sci U S A (1988) 1.02
The epidemiology of mental retardation of unknown cause. Pediatrics (2001) 1.00
X chromosome-wide analyses of genomic DNA methylation states and gene expression in male and female neutrophils. Proc Natl Acad Sci U S A (2010) 0.97
Inactive X chromosome has the highest concentration of unmethylated Hha I sites. Proc Natl Acad Sci U S A (1988) 0.93
Variability of X chromosome inactivation: effect on levels of TIMP1 RNA and role of DNA methylation. Hum Genet (2002) 0.92
Methylation analysis by DNA immunoprecipitation (MeDIP). Methods Mol Biol (2009) 0.89
X-chromosome activity: impact of imprinting and chromatin structure. Int J Dev Biol (1996) 0.89
Analysis of methylation and distribution of CpG sequences on human active and inactive X chromosomes by in situ nick translation. Chromosoma (1990) 0.88
MAOA and GYG2 are submitted to X chromosome inactivation in human fibroblasts. Epigenetics (2009) 0.80
Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells. Nat Genet (2005) 15.37
A comprehensive analysis of common copy-number variations in the human genome. Am J Hum Genet (2006) 8.61
A tiling resolution DNA microarray with complete coverage of the human genome. Nat Genet (2004) 7.68
The functional role of long non-coding RNA in human carcinomas. Mol Cancer (2011) 6.37
RNA polymerase II elongation factors of Saccharomyces cerevisiae: a targeted proteomics approach. Mol Cell Biol (2002) 5.04
Low early-life social class leaves a biological residue manifested by decreased glucocorticoid and increased proinflammatory signaling. Proc Natl Acad Sci U S A (2009) 4.11
Resolving the resolution of array CGH. Genomics (2007) 3.66
PIK3CA mutations and copy number gains in human lung cancers. Cancer Res (2008) 3.42
Factors underlying variable DNA methylation in a human community cohort. Proc Natl Acad Sci U S A (2012) 3.20
Additional annotation enhances potential for biologically-relevant analysis of the Illumina Infinium HumanMethylation450 BeadChip array. Epigenetics Chromatin (2013) 2.93
Linking cell cycle to histone modifications: SBF and H2B monoubiquitination machinery and cell-cycle regulation of H3K79 dimethylation. Mol Cell (2009) 2.91
Alterations in genes of the EGFR signaling pathway and their relationship to EGFR tyrosine kinase inhibitor sensitivity in lung cancer cell lines. PLoS One (2009) 2.79
Integrating copy number polymorphisms into array CGH analysis using a robust HMM. Bioinformatics (2006) 2.50
Silencing of the mammalian X chromosome. Annu Rev Genomics Hum Genet (2005) 2.47
Multiple microalterations detected at high frequency in oral cancer. Cancer Res (2005) 2.47
Human cancer long non-coding RNA transcriptomes. PLoS One (2011) 2.38
Characterisation of retinoblastomas without RB1 mutations: genomic, gene expression, and clinical studies. Lancet Oncol (2013) 2.32
Effect of chorioamnionitis on brain development and injury in premature newborns. Ann Neurol (2009) 2.18
Different measures of "genome-wide" DNA methylation exhibit unique properties in placental and somatic tissues. Epigenetics (2012) 2.17
High resolution analysis of non-small cell lung cancer cell lines by whole genome tiling path array CGH. Int J Cancer (2006) 2.16
Genome-scale analysis of DNA methylation in lung adenocarcinoma and integration with mRNA expression. Genome Res (2012) 2.10
A stepwise framework for the normalization of array CGH data. BMC Bioinformatics (2005) 2.08
Epigenetic vestiges of early developmental adversity: childhood stress exposure and DNA methylation in adolescence. Child Dev (2011) 2.07
The specificity and topology of chromatin interaction pathways in yeast. Mol Cell (2011) 2.04
SeeGH--a software tool for visualization of whole genome array comparative genomic hybridization data. BMC Bioinformatics (2004) 2.04
Population-specificity of human DNA methylation. Genome Biol (2012) 2.04
Comprehensive copy number profiles of breast cancer cell model genomes. Breast Cancer Res (2006) 2.02
Oncogene mutations, copy number gains and mutant allele specific imbalance (MASI) frequently occur together in tumor cells. PLoS One (2009) 1.94
Lung cancer cell lines as tools for biomedical discovery and research. J Natl Cancer Inst (2010) 1.92
The human placenta methylome. Proc Natl Acad Sci U S A (2013) 1.86
Social stress up-regulates inflammatory gene expression in the leukocyte transcriptome via β-adrenergic induction of myelopoiesis. Proc Natl Acad Sci U S A (2013) 1.81
Acquired TNFRSF14 mutations in follicular lymphoma are associated with worse prognosis. Cancer Res (2010) 1.79
Patient-derived first generation xenografts of non-small cell lung cancers: promising tools for predicting drug responses for personalized chemotherapy. Clin Cancer Res (2010) 1.77
3p14 and 9p21 loss is a simple tool for predicting second oral malignancy at previously treated oral cancer sites. Cancer Res (2002) 1.75
Translating dosage compensation to trisomy 21. Nature (2013) 1.75
EZH2 promotes E2F-driven SCLC tumorigenesis through modulation of apoptosis and cell-cycle regulation. J Thorac Oncol (2013) 1.72
R-loop-mediated genome instability in mRNA cleavage and polyadenylation mutants. Genes Dev (2012) 1.69
FMR1 repeat sizes in the gray zone and high end of the normal range are associated with premature ovarian failure. Hum Genet (2005) 1.67
Slx4 regulates DNA damage checkpoint-dependent phosphorylation of the BRCT domain protein Rtt107/Esc4. Mol Biol Cell (2005) 1.66
Recent advances in array comparative genomic hybridization technologies and their applications in human genetics. Eur J Hum Genet (2006) 1.61
Channel interaction in cochlear implant users evaluated using the electrically evoked compound action potential. Audiol Neurootol (2004) 1.58
DNA methylation profiling of human placentas reveals promoter hypomethylation of multiple genes in early-onset preeclampsia. Eur J Hum Genet (2010) 1.55
Acquired resistance to EGFR inhibitors is associated with a manifestation of stem cell-like properties in cancer cells. Cancer Res (2013) 1.54
Modeling recurrent DNA copy number alterations in array CGH data. Bioinformatics (2007) 1.52
Genetic alteration and gene expression modulation during cancer progression. Mol Cancer (2004) 1.50
Effect of active smoking on the human bronchial epithelium transcriptome. BMC Genomics (2007) 1.50
MET gene amplification or EGFR mutation activate MET in lung cancers untreated with EGFR tyrosine kinase inhibitors. Int J Cancer (2009) 1.48
YEATS domain proteins: a diverse family with many links to chromatin modification and transcription. Biochem Cell Biol (2009) 1.44
Toluidine blue staining identifies high-risk primary oral premalignant lesions with poor outcome. Cancer Res (2005) 1.44
TRAF6 is an amplified oncogene bridging the RAS and NF-κB pathways in human lung cancer. J Clin Invest (2011) 1.42
Epigenomics: mapping the methylome. Cell Cycle (2006) 1.42
Evidence for widespread changes in promoter methylation profile in human placenta in response to increasing gestational age and environmental/stochastic factors. BMC Genomics (2011) 1.39
Integrative genomic analyses identify BRF2 as a novel lineage-specific oncogene in lung squamous cell carcinoma. PLoS Med (2010) 1.38
Identification of a long non-coding RNA as a novel biomarker and potential therapeutic target for metastatic prostate cancer. Oncotarget (2014) 1.38
Fertility and aging: do reproductive-aged Canadian women know what they need to know? Fertil Steril (2009) 1.36
Genome-wide identification of human microRNAs located in leukemia-associated genomic alterations. Blood (2010) 1.36
High-resolution array CGH increases heterogeneity tolerance in the analysis of clinical samples. Genomics (2005) 1.35
Mechanisms of X-chromosome inactivation. Front Biosci (2006) 1.34
Array CGH technologies and their applications to cancer genomes. Chromosome Res (2005) 1.33
Dot1 and histone H3K79 methylation in natural telomeric and HM silencing. Mol Cell (2011) 1.32
Multiple aberrations of chromosome 3p detected in oral premalignant lesions. Cancer Prev Res (Phila) (2008) 1.30
Splitting the task: Ubp8 and Ubp10 deubiquitinate different cellular pools of H2BK123. Genes Dev (2011) 1.30
DNA extraction from paraffin embedded material for genetic and epigenetic analyses. J Vis Exp (2011) 1.27
Comprehensive whole genome array CGH profiling of mantle cell lymphoma model genomes. Hum Mol Genet (2004) 1.27
Widespread DNA hypomethylation at gene enhancer regions in placentas associated with early-onset pre-eclampsia. Mol Hum Reprod (2013) 1.25
Whole-genome analysis and HLA genotyping of enteropathy-type T-cell lymphoma reveals 2 distinct lymphoma subtypes. Gastroenterology (2007) 1.25
Copy number alterations of c-MYC and PTEN are prognostic factors for relapse after prostate cancer radiotherapy. Cancer (2012) 1.23
Cytogenetically balanced translocations are associated with focal copy number alterations. Hum Genet (2006) 1.23
Inactive X chromosome-specific reduction in placental DNA methylation. Hum Mol Genet (2009) 1.22
Investigations of the genomic region that contains the clf1 mutation, a causal gene in multifactorial cleft lip and palate in mice. Birth Defects Res A Clin Mol Teratol (2005) 1.21
Roles for H2A.Z and its acetylation in GAL1 transcription and gene induction, but not GAL1-transcriptional memory. PLoS Biol (2010) 1.20
Methods for high throughput validation of amplified fragment pools of BAC DNA for constructing high resolution CGH arrays. BMC Genomics (2004) 1.19
MECP2 promoter methylation and X chromosome inactivation in autism. Autism Res (2008) 1.19
Internal auditory canal morphology in children with cochlear nerve deficiency. Otol Neurotol (2006) 1.19
Epigenetics of cancer progression. Pharmacogenomics (2008) 1.18
NuA4 and SWR1-C: two chromatin-modifying complexes with overlapping functions and components. Biochem Cell Biol (2009) 1.18
The clinical application of potentials evoked from the peripheral auditory system. Hear Res (2008) 1.18
Arsenic exposure and the induction of human cancers. J Toxicol (2011) 1.16
DNA methylation changes in whole blood is associated with exposure to the environmental contaminants, mercury, lead, cadmium and bisphenol A, in women undergoing ovarian stimulation for IVF. Hum Reprod (2012) 1.16
Whole genome tiling path array CGH analysis of segmental copy number alterations in cervical cancer cell lines. Int J Cancer (2007) 1.14
Genomic markers for malignant progression in pulmonary adenocarcinoma with bronchioloalveolar features. Proc Natl Acad Sci U S A (2008) 1.14
Decreased fibronectin production significantly contributes to dysregulated repair of asthmatic epithelium. Am J Respir Crit Care Med (2010) 1.14
Human placental-specific epipolymorphism and its association with adverse pregnancy outcomes. PLoS One (2009) 1.14